Silverberry Genomix Announces Formation of IRB (Internal Review Board)

San Francisco, July 28, 2017 –  Silverberry Genomix, the DNA lifestyle Company today announced formation of its internal IRB (Internal Review Board) for research and studies.

“Internal Review Boards are usually created by research organizations or government agencies to ensure ethical aspects of research and how users’ data is handled are supervised”, said Shayan Mashatian, CEO of Silverberry Genomix. “however, as many more companies at various sizes are joining the fast growing sector of interpreting health and genomics data, there is a need to self-regulate such activities beyond legal requirements” he continued.

In today’s  world of advanced science and technology, where new scientific findings can be converted to products and services through advanced technologies, it is important to think about long term effect of ethical and social implications of such studies as well as their legal aspects.

Therefore, at Silverberry Genomix, we have formed a committee of experts, inside and outside the company to discuss and supervise our studies’ methods and practices with user data, and publishing the results.

Silverberry’s IRB Committee is supervised by Susan Helm,  a healthcare industry veteran and Director of IRB at Pepperdine University.

About Silverberry Genomix

Silverberry Genomix is a DNA Lifestyle Company which utilizes the latest advances in genomics science and machine learning methods (AI) to generate personalized wellness reports based on your genes. Using the saliva sample, 150 Reports are generated in the areas of Nutrition, Exercise, Skincare, Allergy and Personality Development.
For more information contact info@silverberrygenomix.com

Dr. Ahmad Salehi, Prominent Alzheimer Researcher Joins Silverberry as the Director of Cognitive Group

San Francisco, July 15, 2017 – We are pleased to announce  appointment of Dr. Ahmad Salehi, the prominent neuroscientist with many years of research focused on alzheimer’s and cognitive function, as the Director of Cognitive Group.

Dr. Salehi obtained his M.D. from the SBMU in Tehran and his Ph.D. in Neurobiology from the Netherlands Institute for Brain Research in Amsterdam. During this period, he was chosen as the best Junior Neuroscientist in the field of Alzheimer’s disease at the University of Leiden, the Netherlands. Following postdoctoral training(s) at the Netherlands Institute for Brain Research and the Department of Neurology and Neurological Sciences at Stanford Medical School in Palo Alto, California, he worked as a Senior Scientist at Stanford Medical School for more than 8 years.

In 2010, he received the World Technology Award in the field of biotechnology from the World Technology Network in Manhattan, New York for the use of multiple mouse models to identify genes involved in the pathogenesis of Down syndrome and Alzheimer’s disease. Salehi has numerous publications in peer-reviewed and high impact factor international journals of which, 7 have been featured on the cover.

Dr. Salehi will lead Silverberry research to study correlation among genetic predispositions and cognitive function for screening and potentially prevention or treatment of the disease.

About Silverberry Genomix

Silverberry Genomix is a DNA Lifestyle Company which utilizes the latest advances in genomics science and machine learning methods (AI) to generate personalized wellness reports based on your genes. Using the saliva sample, 150 Reports are generated in the areas of Nutrition, Exercise, Skincare, Allergy and Personality Development.
For more information contact info@silverberrygenomix.com